Teladoc Health, Inc. (TDOC) Guidance & Earnings Results
On 2026-07-29 Teladoc Health, Inc. lowered guidance: "Lowered BetterHelp segment revenue…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
TDOCTeladoc Health, Inc.Follow TDOC — free
—
Price chart with a free account
- Market cap
- 1.2B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 28 Oct, in 3 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 29 Jul 26 | Lowered | Lowered BetterHelp segment revenue outlook · full year |
| 29 Apr 26 | Reaffirmed | Full-year 2026 revenue $2,481M-$2,576M; Adjusted EBITDA $267M-$306M · full year |
| 23 Oct 25 | Reaffirmed | FY2025 consolidated revenue and adjusted EBITDA outlook reaffirmed · full year |
| 29 Jul 25 | Reaffirmed | FY25 revenue $2,501-2,548M; adj. EBITDA $263-294M; FCF $170-200M; Q3 revenue $614-636M; adj. EBITDA $56-70M; U.S. Integrated Care Members 101-103M; Integrated Care revenue growth 1.75-3.25%; BetterHelp revenue growth -9.20% to -6.80% · full year |
Teladoc Health, Inc. — questions
- What guidance did Teladoc Health, Inc. give?
- On 2026-07-29: "Lowered BetterHelp segment revenue outlook"
- When does Teladoc Health, Inc. report earnings?
- Teladoc Health, Inc.'s next earnings report is expected on 2026-10-28.
Every figure on this page comes from Teladoc Health, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.